Virometix Completes Enrollment In V-212 Phase I Trial
29 Sep 2025 //
BUSINESSWIRE
Virometix Appoints Christina as Chair And Board Member
08 Oct 2024 //
BUSINESSWIRE
Virometix Announces Publication of Key Non-Clinical Proof-of-Concept Data
14 Jul 2021 //
BUSINESS WIRE
Virometix Announces Publication of Key Non-Clinical Proof-of-Concept Data
14 Jul 2021 //
BUSINESS WIRE
Virometix completes Vaccination of the First Dose in Phase 1 Study with V-306
17 Sep 2020 //
BUSINESSWIRE